News

Discovering Tom™: The Future of AI in Primary Care

Discovering Tom™: The Future of AI in Primary Care

Introducing Tom™: A Game-Changer in Primary Care

In a significant advancement for the healthcare industry, Lumeris has unveiled Tom™, a groundbreaking AI-powered solution aimed at overcoming the primary care accessibility crisis. Defined as the industry's first Primary Care as a Service™ offering, Tom™ is set to bridge the staggering 2-billion-hour gap in primary care services, thereby improving access for the millions who need it most.

Understanding the Primary Care Crisis

Primary care functions as the backbone of effective healthcare delivery. It plays a crucial role in managing chronic diseases, ensuring positive health outcomes, and keeping healthcare costs in check. However, the current landscape reveals a troubling reality. Approximately 100 million Americans lack access to adequate primary care services. The ongoing demand far exceeds supply, further exacerbating healthcare inequities. Traditional solutions are insufficient to fill this void, indicating a dire need for innovative approaches.

Meet Tom™: Your AI-Powered Partner

Tom™ is engineered to revolutionize how primary care is delivered. Through its integration into clinical workflows, it serves as a proactive team member, extending the reach of primary care providers. By focusing on areas such as prevention, wellness, care coordination, and chronic disease management, Tom™ aims to reduce administrative burdens while enhancing patient care.

What Makes Tom Unique?

Unlike conventional systems that only report data to care teams, Tom™ actively engages in patient management. Operating continuously, it autonomously coordinates tasks like scheduling appointments, reinforcing medication adherence, and facilitating educational outreach. This innovative approach not only alleviates the strain on healthcare professionals but also expands the number of patients they can effectively serve.

Real-Time Insights to Empower Providers

Equipped with advanced analytics, Tom™ delivers vital data-driven insights at the point of care, which boosts clinical decision-making and fine-tunes patient interventions. By integrating social determinants of health, Tom™ enhances patient engagement and supports care teams in narrowing the primary care gap.

Executive Perspectives on Tom

Mike Long, chairman and CEO of Lumeris, asserts, "We are addressing the profound 2-billion-hour shortage in primary care head-on. The challenges we face are beyond the reach of any single entity; collaboration is essential. We are thankful for the support Tom is gaining from various top-tier organizations in healthcare and technology across the country."

A Collaborative Vision for Healthcare Transformation

The joint efforts between Lumeris and leading healthcare organizations signal a robust strategy to adapt to current realities. Their collaborations include partnerships with:

  • BJC Health System's Center for Health AI aims to enhance patient care through AI efficiency assessments.
  • Endeavor Health encompasses a health system serving over 1.3 million patients, focusing on comprehensive care delivery.
  • MIT Computer Science and AI Lab contributes to refining patient care optimization algorithms.
  • Oliver Wyman, a premier consulting firm, supports strategic and operational improvements in healthcare.
  • ?URA, known for wearable health technology, extends patient support beyond clinical confines.
  • Wolters Kluwer provides clinical decision support tools that inform over two million healthcare providers globally.

Long emphasizes, "Combining Tom with our partners' expertise opens the door to a pioneering primary care system that can meet patients' needs affordably and equitably."

Honoring a Legacy Through Innovation

In a poignant nod to the legacy of Dr. Tom Doerr—one of Lumeris's founders—Tom™ symbolizes an ongoing commitment to patient-centered primary care. Dr. Doerr championed accessible healthcare and fostered innovations to improve patient experiences. His vision now manifests in this AI-driven solution, paving the way for broader access and enhanced quality in healthcare delivery.

About Lumeris

Founded in 2012, Lumeris is at the forefront of value-based care transformation, working collaboratively with health systems nationwide. With a focus on primary care-led solutions, Lumeris’s tailored models drive quality improvements and cost reductions. The company’s technological innovations, powered by Tom™, have led to exemplary quality metrics and bolstered patient satisfaction across various healthcare sectors, including Medicare and Medicaid. Lumeris employs a skilled workforce of 1,200 professionals and continues to make significant strides in transforming healthcare for millions of Americans.

Frequently Asked Questions

What is Tom™?

Tom™ is an AI-powered solution from Lumeris designed to enhance primary care access and efficiency by automating various tasks within healthcare workflows.

How does Tom™ improve primary care delivery?

Tom™ lowers administrative burdens, assists in scheduling, and provides real-time data insights to support healthcare providers in decision-making.

Who benefits from Tom™?

Tom™ aims to extend primary care access to 100 million Americans, improving healthcare quality and reducing costs for patients and providers alike.

What organizations are collaborating with Lumeris on Tom™?

Collaborating organizations include BJC Health System, Endeavor Health, the MIT Lab, and more, all contributing to enhancing primary care delivery.

What is Lumeris's mission?

Lumeris seeks to transform healthcare through innovative, primary care-led value-based models that improve quality and enhance patient satisfaction across various populations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 417

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 410

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 33

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 126

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 204

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 246

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuits Update for RTO and CUBI Investors

Updated Category News Views 221

Important Class Actions for Shareholders Investors should stay informed about the growing trend of class action lawsuits filed on behalf of shareholders in various publicly-traded companies. These lawsuits often arise from allegations of misleading statements made by the companies' management. Among the latest developments are cases involving Rentokil Initial plc (NASDAQ:...

Continue Reading
TransPerfect's GlobalLink Recognized for Excellence in Localization

Updated Category News Views 75

TransPerfect's GlobalLink Achieves Remarkable Recognition TransPerfect, the premier provider of language and AI solutions for global businesses, has achieved exceptional recognition with its GlobalLink platform. According to the G2 Fall 2024 Report, GlobalLink stands out as a top Enterprise Translation Management Software and Enterprise Website Translation Tool. This...

Continue Reading
Discover the Top U.S. Cities for Affordable Living Choices

Updated Category News Views 337

New Insights on Affordable Living in U.S. Cities A recent survey has ignited discussions on where to find the best cost-effective living environments across the United States. The research indicates a growing need for affordable housing that doesn’t forsake quality of life. In a world where the price of urban living continues to climb, this study by Advance America...

Continue Reading
Hilton USA Trust 2016-SFP CMBS: Navigating Upcoming Changes

Updated Category News Views 261

Understanding the Recent Changes in Hilton USA Trust 2016-SFP CMBS Investors holding the Hilton USA Trust 2016-SFP commercial mortgage pass-through certificates should be aware of significant upcoming changes regarding the special servicer of their loans. Recently, Wells Fargo Bank, N.A. has been involved in the management of these loans, which were placed under special...

Continue Reading
Exclusive CBD Agreement Between Avecho and Sandoz for Insomnia

Updated Category News Views 189

Exclusive Partnership Between Avecho and Sandoz Avecho Biotechnology Limited is thrilled to announce a groundbreaking partnership with Sandoz Group AG. This agreement marks a significant milestone for Avecho as it aims to commercialize its innovative cannabidiol capsule designed specifically for insomnia. With the exclusive license and development agreement now in place,...

Continue Reading